Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Recall

Ongoing
Drugs
Class II — Moderate

Recall Date

Apr 15, 2026

Company

Teva Pharmaceuticals USA, Inc

Source

FDA

Units

62,136 Cartons

Reason: CGMP Deviations: use of an unapproved raw material

Official FDA recall notice

Information is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.

Recall Details

Description

CGMP Deviations: use of an unapproved raw material

Reason for Recall

CGMP Deviations: use of an unapproved raw material

What Should I Do?

Quantity: 62,136 Cartons

Remediation GuideAction Required

5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.

1
Confirm Your Product Is Affected
2
Read the Full Recall Notice
3
Stop Using the Product if in Doubt

+2 more steps…

View Official Recall Notice (FDA)

Last updated April 20, 2026

Injured by a recalled product?

Our legal partners offer free consultations for recall victims.

Get Free Legal Help →Sponsored

Stay Informed

Weekly recall digest — free, no spam.